Key result
OACs, ablation, BP control, and integrated management are linked to lower dementia risk in AF.
Why the study?
Solid evidence has been lacking that any specific treatment prevents or delays AF-associated cognitive decline, though evidence is accumulating on possible strategies.
Do various treatment strategies (anticoagulation, ablation, blood pressure control) reduce the risk of dementia in patients with atrial fibrillation?
Do various treatment strategies (anticoagulation, ablation, blood pressure control) reduce the risk of dementia in patients with atrial fibrillation?
This review highlights that proactive management of atrial fibrillation, including the use of non-vitamin K antagonist oral anticoagulants, catheter ablation, and strict blood pressure control, may reduce the risk of incident dementia.
Answers are grounded in this paper and cite their sources.
May support integrated AF management to potentially lower dementia risk; leaves open confirmation in randomized trials.
Atrial fibrillation (AF) has been associated with an increased risk of dementia.Although there does not appear to be solid evidence that any specific treatment prevents or delays AF-associated cognitive decline, evidence is accumulating regarding the possible treatment strategies for preventing dementia.In this review, we summarize the evidence linking AF to dementia and critically appraise the proposed treatment strategies. ABSTRACTAtrial fibrillation (AF) is the most common form of arrhythmia in the elderly population and increases stroke risk by a factor of 4-to 5-fold.There is increasing evidence to suggest that incident AF may contribute to the development of dementia, independent of overt stroke.In particular, relatively younger patients with AF are more prone to dementia development than older patients with AF.Evidence is accumulating regarding the possible treatment strategies for preventing dementia in patients with AF.Oral anticoagulation may be effective for reducing the risk of dementia, even in patients with low stroke risks.Among oral anticoagulants, the use of non-vitamin K antagonists have been associated with a considerably decreased risk of dementia than warfarin.Moreover, successful catheter ablation for AF has also been associated with decreased dementia risk compared to medical therapy, suggesting that restoration of sinus rhythm, and not the ablation procedure itself, as the important mechanism in the prevention of AF-associated dementia.Among midlife patients with AF, there appeared to be a U-shaped association of blood pressure (BP) and a linear association of hypertension with dementia risk.A BP of 120 to 129/80 to 84 mmHg has been identified as the optimal range.Finally, integrated management of AF was associated with a reduced risk of dementia in AF patients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) conducted a review in Atrial Fibrillation and Dementia. Oral anticoagulants, catheter ablation, blood pressure control, and integrated management was evaluated. Oral anticoagulation (particularly NOACs), catheter ablation, optimal blood pressure control, and integrated management are associated with a reduced risk of dementia in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: